Missouri State University
Springfield - 91.1
Branson - 90.5
West Plains - 90.3
Mountain Grove - 88.7
Joplin - 98.9
Neosho - 103.7
Share |

It look's like you don't have Adobe Flash Player installed. Get it now.

Lawmakers End the First Half of Session

Lawmakers left Jefferson City on Thursday for their annual Spring Break. But before heading home, legislative leaders reflected on the first half of the legislative session. KSMU's Missy Shelton reports.

On the last day before the legislative Spring Break, House Speaker Rod Jetton said the legislature has addressed important issues since it convened in January.

Most notably, lawmakers sent the governor bills that limit liability lawsuits and make it more difficult for injured workers to get compensation, both are priorities of the business community.

Before heading out of town, House Democrats held a press conference.

The democratic leader Jeff Harris had harsh words for Republican Governor Matt Blunt.

In a written statement, the governor's spokeswoman urged Jeff Harris to explain quote-"why it is moral to destroy a family's job by raising taxes."

When asked how to balance the state's declining revenue with increasing demand for state services, Harris said he's waiting for the governor to lay out a vision for the state.

But the day before the legislative Spring Break wasn't entirely partisan.

On Thursday, House Speaker Rod Jetton unveiled a bi-partisan prescription drug plan that would allow Missouri residents to buy prescription drugs through qualified pharmacies in Canada.

The proposal would codify a program former Democratic Governor Bob Holden created through an executive order.

Jetton says it's a way to help Missourians save money.

The legislature comes back into session on Tuesday March 29th.

The budget will take a lot of time and attention during the last part of the session.

Lawmakers also are expected to deal with a wide range of issues from the creation of a new mechanism to distribute state funding to public schools to a ban on embryonic stem cell research.